Dr. Saul Hertz Discovers the Medical Uses of Radioiodine (RAI)
Journal Title: Journal of Radiology and Oncology - Year 2018, Vol 2, Issue 3
Abstract
Primary sources document Dr. Saul Hertz (1905 - 1950) as conceiving and developing radioiodine (RAI) as a diagnostic tool and as a therapy for thyroid diseases. Dr. Hertz was the first and foremost person to develop the experimental data on RAI and apply it to the clinical setting.
Authors and Affiliations
B Hertz
Keywords
Related Articles
- EP ID EP536290
- DOI 10.29328/journal.jro.1001022
- Views 99
- Downloads 0
Ra-223 dichloride management in a Nuclear Medicine Unit: experience of a referral institution
Ra-223 dichloride is a first-in-class alpha-emitting radiopharmaceutical recently introduced into clinical practice for treatment of men with Castration-Resistant Prostate Cancer (CRPC) and symptomatic bone metastases. D...
Using Mathematical Procedure to Compute the Attenuation Coefficient in Spectrometry Field
In gamma-ray spectrometry, the analysis of the environmental radioactivity samples (soil, sediment and ash of a living organism) needs to know the linear attenuation coefficient of the sample matrix. This coefficient is...
Radiological evaluation of a Chondromyxoid Fibroma
Chondromyxoid fibroma (CMF) is a very rare benign cartilaginous tumor representing less than 0.5% of all bone tumors while also being the rarest cartilaginous bone tumor. Common locations of occurrence include the metaph...
Dr. Saul Hertz Discovers the Medical Uses of Radioiodine (RAI)
Primary sources document Dr. Saul Hertz (1905 - 1950) as conceiving and developing radioiodine (RAI) as a diagnostic tool and as a therapy for thyroid diseases. Dr. Hertz was the first and foremost person to develop the...
Estimation of Serum Beta 2- microglobulin among newly diagnosed children with cancer in Basra
Background: Beta 2- micro globulin (β2-MG) is involved in human malignancies. Increased synthesis and release of β2-MG, as indicated by elevated serum, plasma, or urine β2-MG concentration, occurs in several malignant di...